CollPlant Biotechnologies Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 52
Employees
  • Latest Deal Type
  • PIPE
  • Latest Deal Amount
  • $4.45M
Latest Deal Amount
  • Investors
  • 3

CollPlant Biotechnologies General Information

Description

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Therapeutic Devices
Primary Office
  • Oppenheimer 4
  • Rehovot 7670104
  • Israel
+972 000-000-0000

CollPlant Biotechnologies Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CollPlant Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. PIPE 14-Feb-2020 $4.45M 000.00 Completed Generating Revenue
5. PIPE 01-May-2018 000.00 000.00 Completed Generating Revenue
4. 2PO 21-Oct-2016 0000 Cancelled Generating Revenue
3. IPO 14-Oct-2007 00.00 Completed Generating Revenue
2. Early Stage VC 13-Feb-2007 $2M $3.5M 0000 Completed Generating Revenue
1. Early Stage VC 04-Sep-2006 $1.5M $1.5M 000 Completed Generating Revenue
To view CollPlant Biotechnologies’s complete valuation and funding history, request access »

CollPlant Biotechnologies Executive Team (9)

Name Title Board Seat Contact Info
Yehiel Tal Chief Executive Officer
Eran Rotem Chief Financial Officer, Finance & Executive
Ilana Belzer Ph.D Chief Operating Officer, Operations
Oded Shoseyov Ph.D Founder & Executive
Hadas Horowitz Vice President
You’re viewing 5 of 9 executive team members. Get the full list »

CollPlant Biotechnologies Board Members (13)

Name Representing Role Since
Abraham Havron Ph.D Self Board Member 000 0000
Elan Penn Self Board Member 000 0000
Gili Hart Ph.D Self Board Member 000 0000
Hugh Evans Self Board Member 000 0000
Joseph Zarzewsky Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

CollPlant Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CollPlant Biotechnologies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Alpha Capital Anstalt Corporation Minority 000 0000 000000 0
Meitav Underwriting Corporation Minority 000 0000 000000 0
Rocky Point Ventures Venture Capital Minority 000 0000 000000 0
To view CollPlant Biotechnologies’s complete investors history, request access »